Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

about

Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer.

P2860

Q28072513-657BE0A8-FAB4-420F-9C21-D9EF4D138204 Q39251886-2318712F-60EE-4862-BA3B-ADBFE0051F7A

P2860

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

Item

http://www.wikidata.org/entity/Q26752024

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@ast

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@en

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@nl

type

Item

label

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@ast

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@en

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@nl

prefLabel

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@ast

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@en

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@nl

P1476

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

@en

P2093

Elżbieta Nowara

http://www.w3.org/2001/XMLSchema#string

Joanna Huszno

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2016.58495

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27095932

http://www.w3.org/2001/XMLSchema#string

P932

4829743

http://www.w3.org/2001/XMLSchema#string

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

about

P2860

P2860

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932